Neurological Monitoring During Extracorporeal Membrane Oxygenation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02020759|
Recruitment Status : Recruiting
First Posted : December 25, 2013
Last Update Posted : April 4, 2017
Neurological complications are frequent during extracorporeal membrane oxygenation (ECMO) representing a crucial factor for patient outcome. However, to date there is no consensus with regard to optimal neurological monitoring of patients undergoing ECMO.
The aim of this study is to monitor patients using transcranial Doppler (TCD) ultrasound and near-infrared spectroscopy (NIRS) during ECMO therapy.
The study hypothesis is that TCD and NIRS technology are sufficient tools to detect cerebral embolism and hypoperfusion during ECMO therapy.
|Condition or disease||Intervention/treatment|
|Complication of Extracorporeal Membrane Oxygenation Cerebral Embolism Cerebral Hypoperfusion||Device: Transcranial Doppler Ultrasound|
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Multimodal Neurological Monitoring in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO) - a Prospective Observational Pilot Study.|
|Study Start Date :||December 2013|
|Estimated Primary Completion Date :||February 2018|
|Estimated Study Completion Date :||March 2018|
Patient on ECMO
Device: Transcranial Doppler Ultrasound
Transcranial Doppler Ultrasound is used to monitor cerebral embolism Near-Infrared Spectroscopy is used to detect cerebral hypoperfusion
Other Name: Near-Infrared Spectroscopy
- Cerebral embolic load [ Time Frame: 30 minutes ]Cerebral embolic load (solid and gaseous) is measured in a 30 minutes-interval during ECMO usage
- Regional cerebral oxygenation [ Time Frame: 30 minutes ]Regional cerebral oxygenation is measured in a 30 minutes-interval during ECMO usage.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02020759
|Contact: Gabor Erdoes, MD||0043 1 40400 ext email@example.com|
|Contact: Ulrich Klein, MD||0043 1 40400 ext firstname.lastname@example.org|
|Medical University of Vienna||Recruiting|
|Vienna, Austria, 1090|
|Contact: Gabor Erdoes, MD 0043 40400 ext 4102 email@example.com|
|Contact: Klaus Markstaller, Md, PhD 0043 40400 ext 4102 firstname.lastname@example.org|
|Principal Investigator: Gabor Erdoes, MD|
|Principal Investigator:||Gabor Erdoes, MD||Medical University of Vienna|